Experimental stroke drug takes first step in human safety trial
Disease control
Terminated
This trial tests the safety of a single intravenous dose of an experimental drug called NTS-104 tris in healthy adults aged 18 to 65. The drug is being developed as a potential treatment for acute ischemic stroke. Researchers will monitor participants for side effects and measure…
Phase: PHASE1 • Sponsor: NeuroTrauma Sciences, LLC • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC